These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9499451)

  • 21. Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screening.
    Hill BT; Whelan RD; Hosking LK
    Invest New Drugs; 1988 Apr; 6(1):11-8. PubMed ID: 3410662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 2 study of sodium phenylbutyrate in ALS.
    Cudkowicz ME; Andres PL; Macdonald SA; Bedlack RS; Choudry R; Brown RH; Zhang H; Schoenfeld DA; Shefner J; Matson S; Matson WR; Ferrante RJ;
    Amyotroph Lateral Scler; 2009 Apr; 10(2):99-106. PubMed ID: 18688762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vivo assessment on the therapeutic effects of etoposide, vincristine and mitomycin C against human neuroblastoma].
    Kaneko M; Kaneko S; Ohkawa H
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1155-61. PubMed ID: 1905121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine.
    Sietsma H; Veldman RJ; Kolk D; Ausema B; Nijhof W; Kamps W; Vellenga E; Kok JW
    Clin Cancer Res; 2000 Mar; 6(3):942-8. PubMed ID: 10741719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR inhibition using gefitinib is not active in neuroblastoma cell lines.
    Rössler J; Odenthal E; Geoerger B; Gerstenmeyer A; Lagodny J; Niemeyer CM; Vassal G
    Anticancer Res; 2009 Apr; 29(4):1327-33. PubMed ID: 19414383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines.
    Entin-Meer M; Rephaeli A; Yang X; Nudelman A; Nudelman A; Haas-Kogan DA
    Cancer Lett; 2007 Aug; 253(2):205-14. PubMed ID: 17346876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis.
    Kollareddy M; Sherrard A; Park JH; Szemes M; Gallacher K; Melegh Z; Oltean S; Michaelis M; Cinatl J; Kaidi A; Malik K
    Cancer Lett; 2017 Sep; 403():74-85. PubMed ID: 28602975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines.
    Keshelava N; Groshen S; Reynolds CP
    Cancer Chemother Pharmacol; 2000; 45(1):1-8. PubMed ID: 10647494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of sodium phenylbutyrate to agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro].
    Gao J; Ruan X; Pan X; Xu F; Lei D; Liu D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Aug; 19(15):680-2. PubMed ID: 16248503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.
    Carducci MA; Nelson JB; Chan-Tack KM; Ayyagari SR; Sweatt WH; Campbell PA; Nelson WG; Simons JW
    Clin Cancer Res; 1996 Feb; 2(2):379-87. PubMed ID: 9816181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-associated angiogenesis in neuroblastoma tumors.
    Michaelis M; Hinsch N; Michaelis UR; Rothweiler F; Simon T; ilhelm Doerr HW; Cinatl J; Cinatl J
    Am J Pathol; 2012 Apr; 180(4):1370-7. PubMed ID: 22285670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of Antitumor Activity of Sodium Phenylbutyrate, Histon Deacetylase Inhibitor, on Ehrlich Carcinoma Model.
    Fadeev NP; Kharisov RI; Kovan'ko EG; Pustovalov YI
    Bull Exp Biol Med; 2015 Sep; 159(5):652-4. PubMed ID: 26468021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
    Ponthan F; Wickström M; Gleissman H; Fuskevåg OM; Segerström L; Sveinbjörnsson B; Redfern CP; Eksborg S; Kogner P; Johnsen JI
    Clin Cancer Res; 2007 Feb; 13(3):1036-44. PubMed ID: 17289900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.
    Zeki J; Taylor JS; Yavuz B; Coburn J; Ikegaki N; Kaplan DL; Chiu B
    Surgery; 2018 Oct; 164(4):909-915. PubMed ID: 30061039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulation of variables in local controlled release vincristine treatment in neuroblastoma.
    Coburn JM; Harris J; Cunningham R; Zeki J; Kaplan DL; Chiu B
    J Pediatr Surg; 2017 Dec; 52(12):2061-2065. PubMed ID: 28927981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms.
    Al-Keilani MS; Al-Sawalha NA
    Chem Res Toxicol; 2017 Oct; 30(10):1767-1777. PubMed ID: 28930444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.
    Tu Y; Cheng S; Zhang S; Sun H; Xu Z
    Int J Mol Med; 2013 Jan; 31(1):113-9. PubMed ID: 23129065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies.
    Abbou S; Lanvers-Kaminsky C; Daudigeos-Dubus E; LE Dret L; Laplace-Builhe C; Molenaar J; Vassal G; Geoerger B;
    Anticancer Res; 2016 Feb; 36(2):599-609. PubMed ID: 26851014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.